Stay updated with breaking news from Global Access Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global Access Diagnostics (GADx), a social enterprise and leading developer of lateral flow and rapid diagnostic technologies, today announced it has expanded the applications of its low-cost, rapid diagnostic test, BotrytisAlert.
Leishmaniasis test reintroduced to the market following regulatory and performance validation for UKCA marking
GADx announces today that Mr Mark Davis is stepping down as CEO and co-founder after 20 years of unwavering service, having created the organisation Mologic Ltd in June 2003 alongside his father and industry leader, Prof. Paul Davis.
Social enterprise Global Access Diagnostics (GADx) has joined a collaboration that will take forward the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, particularly in calves. Click to read more...
Global Access Diagnostics (GADx) today announced the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, one of the most significant diseases affecting calves